Topical instillation of cell-penetrating peptide-conjugated melphalan blocks metastases of retinoblastoma
Retinoblastoma is the most common primary intraocular malignancy in infancy with a metastases-related death risk. However, a safe and convenient treatment without enucleation is still an unmet clinical need. In this work, a cell-penetrating peptide, 89WP, was conjugated with melphalan (89WP-Mel), wh...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier Ltd
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |